News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Rami Manochakian: FDA Approves Taletrectinib for ROS1-Positive Non-Small Cell Lung Cancer Based on TRUST Trials
Rami Manochakian/X
Jun 12, 2025, 19:07

Rami Manochakian: FDA Approves Taletrectinib for ROS1-Positive Non-Small Cell Lung Cancer Based on TRUST Trials

Rami Manochakian, Vice President of the North American Neuroendocrine Tumor Society, shared on X:

“Hot Off The Press
U.S. FDA approves Taletrectinib for locally advanced or metastatic ROS1+ non-small cell Lung Cancer.
Approval based on TRUST I and II Trials.
– ORR:
85-90% for treatment-naive patients
52-62% or TKI-pretreated patients”

Read the full article.

Taletrectinib

More posts featuring Rami Manochakian on OncoDaily.

cancer FDA Lung cancer North American Neuroendocrine Tumor Society NSCLC OncoDaily Oncology Rami Manochakian Taletrectinib trust TRUST trial U.S. FDA
Special Coverage
Voices
Sep 4, 2025, 09:26
Kevin Lo: A Touch of Pink for a Powerful Purpose
Science
Sep 4, 2025, 09:19
Elisa De Paolis: NRG1 VUS Network Analysis and Prognostic Role in EGFR-Mutant NSCLC
FDA Approvals
Sep 4, 2025, 09:08
FDA Grants Breakthrough Therapy Designation to Zongertinib (HERNEXEOS) for First-Line Treatment of HER2-Mutant Advanced NSCLC
Voices
Sep 4, 2025, 09:05
What Problems We’re Addressing and How We’re Supporting Children with Cancer - World Child Cancer USA
Insight
Sep 4, 2025, 08:53
Register Now for ASGCR 2025 Select Sessions - NCI Center for Global Health
Voices
Sep 4, 2025, 08:49
Rob Winn: Ovarian Cancer Awareness Month - Raising Awareness to Change the Future
Voices
Sep 4, 2025, 08:36
Zainab Shinkafi-Bagudu: Delivering Cancer Education at NISS Health Week
Voices
Sep 4, 2025, 08:36
Thoracic Circle is Live! - IASLC
Voices
Sep 4, 2025, 08:27
Breast Cancer Treatment in Low-resource Countries - The Max Foundation
Insight
Sep 4, 2025, 08:13
Society for Integrative Oncology Released New Integrative Oncology eBook
Science
Sep 4, 2025, 08:13
Neil Iyengar: New Report on GLP1 Receptor Agonist Use in Breast Cancer Survivors
Career Updates
Sep 4, 2025, 08:02
Gail Garvey Has Received the 2025 Tom Reeve Award for Outstanding Contribution to Cancer Care - COSA